It is very sad to see our pre-existing holdings being absolutely mass devalued with this one CR move.
All due to compounded FDA/MSB process issues and mismanagement - keeping that very generic as still not sure where the issues fully sit. It has been talked to death and pretty over that.
It hurts as now a shorter term $5 target you may have had before now turns into a $3 target with this dilution.
You can’t undo dilution, and yes we can all buy more but we then have to increase our risk exposure even more which I really was not keen at all in doing any more…as I have bought as much as I really am comfortable to expose myself to.
It is all a bit hard to take. The price has already been smashed down from $1.10 to 33 cents in very recent times and that was a very hard pill to swallow - now swallowing this further mass dilution is like trying to swallow a cement truck fully loaded…it hurts.
In general this CR its not good for pre-existing shareholders even if you buy more. If we wanted more you could have just bought more at .33 to .35 cents - close enough - I get it, MSB need the cash and in the end MSB have to do it to get by and exist to have a chance. But it’s not nice and I would not paint this as good in any way.
Such a shame as I had some distant dreams of potentially a $50 to $100 share price one day long time and now from this one CR mass dilution that will be very hard to achieve. All due to some bloody lame obscure processes and mismanagement.
A CR at .30 means this SP will open at close to .30 and most likely drift below this at some point in the months following.
Sad for everyone.
MSB Price at posting:
40.5¢ Sentiment: Hold Disclosure: Held
(20min delay)